Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,433,639
+$4,071,433 QoQ
Shares Held
624,107
+37.2% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 257 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Derivatives in ERAS
reported options exposure · as of Jun 30, 2026CallValue
$12,752,552
CallShares
696,100
PutValue
$2,964,176
PutShares
161,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. ERAS ranks #22 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in ERAS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,433,639 | 624,107 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $2,964,176 | 161,800 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $12,752,552 | 696,100 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $7,362,206 | 455,019 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $1,163,342 | 71,900 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $1,467,526 | 90,700 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $3,394,568 | 912,519 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $81,840 | 22,000 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $150,660 | 40,500 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $841,629 | 386,069 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $167,980 | 132,269 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $54,376 | 21,664 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $189,904 | 69,562 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $397,451 | 168,412 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $237,397 | 115,242 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $567,546 | 266,454 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $107,294 | 54,464 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $42,087 | 15,249 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $844,497 | 280,564 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $50,892 | 11,808 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $105,744 | 13,557 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $64,606 | 11,599 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $160,458 | 18,658 | Shares | Defined | 2022-05-17 | |
| No filing history on record for this holder in this stock. | ||||||